Worth Venture Partners, LLC Theratechnologies Inc. Transaction History

Worth Venture Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.72 - $1.12 $75,866 - $118,014	-105,370 Reduced 11.07%	846,654 $685,000
Q4 2022 Feb 14, 2023	BUY	$0.83 - $8.04 $173,138 - $1.68 Million	208,601 Added 28.06%	952,024 $837,000
Q2 2022 Aug 15, 2022	SELL	$2.21 - $2.7 $27,492 - $33,588	-12,440 Reduced 1.65%	743,423 $1.62 Million
Q1 2022 May 16, 2022	BUY	$2.37 - $3.24 $189,363 - $258,876	79,900 Added 11.82%	755,863 $1.87 Million
Q4 2021 Feb 14, 2022	SELL	$2.92 - $3.76 $93,685 - $120,635	-32,084 Reduced 4.53%	675,963 $2.04 Million
Q3 2021 Nov 15, 2021	SELL	$3.28 - $4.07 $470,240 - $583,499	-143,366 Reduced 16.84%	708,047 $2.66 Million
Q1 2021 May 17, 2021	BUY	$2.2 - $3.94 $1.55 Million - $2.78 Million	705,251 Added 482.51%	851,413 $3.29 Million
Q4 2020 Feb 17, 2021	BUY	$1.91 - $2.5 $279,169 - $365,405	146,162 New	146,162 $365,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $114M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.